Profile data is unavailable for this security.
About the company
HeiLongJiang ZBD Pharmaceutical Co., Ltd. is a China-based pharmaceutical company engaged in the research and development, manufacture and sales of Chinese patent medicine. The Company's products include freeze-dried powder injections, powder injections, large volume injections, small volume injections, mixture, tablets, capsule, granules, syrup, oral solution, decoction agent and active pharmaceutical ingredient, which are used for the areas of cardiovascular, anti-viral flu, fracture and osteoporosis, immune enhancement and liver protection. The Company distributes its products under the brand named Zhenbaodao.
- Revenue in CNY (TTM)2.22bn
- Net income in CNY522.07m
- Incorporated1996
- Employees2.55k
- LocationHeiLongJiang ZBD Pharmaceutical Co LtdNo. 8Yantai First Road, Pingfang DistrictHAERBIN 150060ChinaCHN
- Phone+86 45 186811969
- Fax+86 45 187105767
- Websitehttp://www.zbdzy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changchun BCHT Biotechnology Co | 1.88bn | 527.23m | 9.13bn | 1.24k | 17.28 | 2.22 | -- | 4.85 | 1.28 | 1.28 | 4.56 | 9.96 | 0.394 | 0.7747 | 1.53 | 1,517,684.00 | 11.03 | 9.95 | 13.51 | 12.81 | 89.44 | 86.63 | 27.99 | 24.03 | 1.99 | -- | 0.0252 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| KPC Pharmaceuticals Inc | 7.49bn | 450.79m | 9.31bn | 5.05k | 20.71 | 1.73 | -- | 1.24 | 0.594 | 0.594 | 9.89 | 7.10 | 0.7847 | 2.43 | 2.66 | 1,482,262.00 | 4.79 | 5.42 | 8.10 | 9.13 | 41.97 | 43.68 | 6.11 | 5.70 | 1.44 | -- | 0.199 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Mayinglong Pharmaceutical Group Co Ltd | 3.42bn | 473.79m | 9.44bn | 2.88k | 19.92 | 2.45 | -- | 2.76 | 1.10 | 1.10 | 7.94 | 8.94 | 0.6648 | 6.05 | 10.01 | 1,188,102.00 | 9.35 | 10.82 | 11.58 | 13.47 | 43.86 | 41.18 | 14.07 | 14.08 | 4.06 | -- | 0.0946 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Liaoning Chengda Biotechnology Co Ltd | 1.76bn | 352.53m | 9.44bn | 1.73k | 26.87 | 0.9885 | -- | 5.37 | 0.8438 | 0.8438 | 4.23 | 22.93 | 0.1766 | 0.7386 | 1.48 | 1,015,870.00 | 3.54 | 10.63 | 3.66 | 11.01 | 81.24 | 85.74 | 20.04 | 39.56 | 17.34 | -- | 0.0019 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 2.22bn | 522.07m | 9.58bn | 2.55k | 18.30 | 1.21 | -- | 4.32 | 0.5556 | 0.5556 | 2.36 | 8.43 | 0.1757 | 0.6759 | 0.6464 | 870,758.90 | 4.10 | 3.48 | 5.54 | 4.78 | 64.84 | 38.93 | 23.37 | 10.08 | 2.18 | -- | 0.2951 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
| Guobang Pharma Ltd | 5.43bn | 659.59m | 10.23bn | 4.23k | 15.50 | 1.34 | -- | 1.88 | 1.18 | 1.18 | 9.72 | 13.70 | 0.5504 | 3.05 | 7.19 | 1,283,877.00 | 6.66 | 10.36 | 8.54 | 14.24 | 23.75 | 27.49 | 12.10 | 15.01 | 1.67 | -- | 0.1799 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
Data as of Sep 13 2024. Currency figures normalised to HeiLongJiang ZBD Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Shenwan Hongyuan Asset Management (Asia) Ltd.as of 30 Sep 2023 | 4.50m | 0.48% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.57m | 0.17% |
| The Vanguard Group, Inc.as of 31 Jul 2024 | 1.43m | 0.15% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 1.39m | 0.15% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 950.90k | 0.10% |
| CCB Principal Asset Management Co., Ltd.as of 29 Feb 2024 | 892.00k | 0.10% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 782.60k | 0.08% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 699.60k | 0.07% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 653.70k | 0.07% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 566.90k | 0.06% |
More ▼
Data from 31 Dec 2023 - 12 Sep 2024Source: FactSet Research Systems Inc.
